GBT021601-022: A Study of GBT021601 in Participants With Sickle Cell Disease (SCD)

Clinical trial NCT05632354 · TERMINATED

Trial details

NCT number: NCT05632354
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2023-01-05
Primary completion: 2025-02-13
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.